Development of Immune Tolerance
Development of Immune Tolerance
批准号:
10338131
负责人:
Michael Archibald Farrar
金额:
$46.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-03-15 至 2026-02-28
关键词:
AffectAntigensAutoantigensAutoimmune DiseasesAutoimmunityBacteriaBiologyCellsComplexCoronavirusDataDendritic CellsDevelopmentDiseaseFOXP3 geneFundingGene ExpressionGenesGrantHybridomasIL2RA geneImiquimodImmuneImmune ToleranceImmune responseInfectious AgentInflammationInfluenzaInterferon Type IInterferon-betaInterferonsLoxP-flanked alleleLupusMediatingModelingMusOrganismPathogenicityPathologyPeptidesPlayPreventionProcessRegulatory T-LymphocyteRoleSTAT1 geneSignal TransductionSjogren&aposs SyndromeSourceSpecificityStromal CellsStructure of parenchyma of lungSystemic Lupus ErythematosusT-Cell Receptor GenesT-LymphocyteTestingThymic epithelial cellThymus GlandTissuesUp-RegulationViralVirusVirus Diseasescell typegenetic signaturein vivoinfluenza infectionmigrationmouse modelnovelpandemic influenzapathogenpreventprogenitorprogramsreduce symptomsresponsesecondary lymphoid organsingle-cell RNA sequencingtranscriptomics
中文摘要
项目摘要
胸腺中自身抗原特异性CD 4 + T细胞的程序化对于抑制异常免疫应答是必需的。
免疫应答和自身免疫的预防。在病毒感染期间,Tactinase还控制炎症,
病原体清除后。这对于某些类型的病毒感染特别相关,例如1918年的
流感大流行毒株,以及最近的冠状病毒的特定毒株,其中免疫反应
本身就可能是致病的。除了病毒感染外,高水平的I型IFN是某些肿瘤的定义特征。
自身免疫性疾病,如SLE或舍格伦综合征; TdR减少这种自身免疫性疾病的症状
疾病也是。然而,我们对上述两个过程中涉及的TdR知之甚少。
例如,在这些反应中涉及哪些类型的T细胞?调节性T细胞会抑制抗病毒免疫吗
反应或抑制SLE样疾病在胸腺中的发展?如果是的话,控制着
这个Treg亚群的分化?这种Treg亚群的分化需要哪些APC/基质细胞?
这个Treg亚群在病毒感染或SLE期间发挥什么特定的功能作用?我们的初步数据
证明了一个独特的亚群TcR在胸腺中发育,其特征是强烈的
干扰素刺激的基因签名(ISG-THEB)。我们认为,ISG-Treg亚群在免疫调节中起着关键作用。
在控制抗病毒免疫应答和抑制自身免疫应答中的作用
以高水平IFN为特征的疾病。我们将在两个具体目标中探讨这一假设。在目标1中,
我们将确定胸腺中的IFN信号传导如何影响胸腺选择和ISG-T细胞的发育。
在目标2中,我们将确定ISG-TdR在病毒感染和系统性狼疮中的功能
尿道炎成功完成这些目标将使我们能够确定ISG-
T细胞在胸腺中产生,并决定ISG-T细胞在对病毒的免疫应答中的作用,
与高水平IFN相关的自身免疫性疾病,如SLE或干燥综合征。
英文摘要
PROJECT SUMMARY
Programming of self-antigen specific CD4+ Tregs in the thymus is essential for suppression of aberrant
immune responses and prevention of autoimmunity. Tregs also control inflammation during viral infection and
following pathogen clearance. This is particularly relevant for some types of viral infections such as the 1918
influenza pandemic strain, and more recently, specific strains of coronaviruses, where the immune response
itself can be pathogenic. In addition to viral infections, high levels of type I IFN are a defining feature of some
autoimmune diseases, such as SLE or Sjögren’s syndrome; Tregs reduce the symptoms of such autoimmune
diseases as well. However, we know relatively little about the Tregs involved in either of the above processes.
For example, what types of Tregs are involved in these responses? Do Tregs that dampen anti-viral immune
responses or suppress SLE-like disease develop in the thymus? If so, what is the thymic niche that controls
differentiation of this Treg subset? What APCs/stromal cells are required for differentiation of this Treg subset?
What specific functional roles does this Treg subset play during viral infections or SLE? Our preliminary data
demonstrate that a unique subset of Tregs develops in the thymus characterized by a strong
interferon-stimulated gene-signature (ISG-Tregs). We propose that this ISG-Treg subset plays a key
role in governing antiviral immune responses and suppressing immune responses to autoimmune
diseases characterized by high levels of IFN. We will explore this hypothesis in two specific aims. In aim 1,
we will determine how IFN signaling in the thymus affects thymic selection and the development of ISG-Tregs.
In aim 2, we will determine the functions of ISG-Tregs in response to viral infections and systemic lupus
erythematosis. Successful completion of these aims will allow us to identify the mechanism by which ISG-
Tregs arise in the thymus, and determine the role of ISG-Tregs in immune responses to viruses, and in
autoimmune diseases associated with high levels of IFN, such as SLE or Sjögren’s syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T Cells in Alzheimer's Disease
-
批准号:10515396
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulation of central tolerance and Treg development by recirculating Treg
-
批准号:10615598
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulatory T Cells in Alzheimer's Disease
-
批准号:10685434
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulation of central tolerance and Treg development by recirculating Treg
-
批准号:10363236
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10614429
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10059179
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10319979
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10550155
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10382260
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Development of Immune Tolerance
-
批准号:10573296
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2016
-
负责人:Michael Archibald Farrar
-
依托单位:
TNF Receptor Superfamily Signaling in Immune Tolerance
-
批准号:8894185
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9063487
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9262063
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:8686567
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8230503
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8307275
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8617815
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8843379
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8105994
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8677789
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: